Sixth Affiliated Hospital, Sun Yat-sen University: Colorectal Neoplasms trials

The registry lists 27 Colorectal Neoplasms studies with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor. 12 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 9No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Superior HypogastrIc plExus bLock During Laparoscopic Colorectal Cancer SurgeryRecruitingNCT07579780Not applicable
• Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)RecruitingNCT06958419Phase 2/3
• Preoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal CancerRecruitingNCT06407518Not applicable
• Development and Validation of a PSN-AI Prediction ModelRecruitingNCT06231524
• Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal CancerRecruitingNCT06192030
• Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCCRecruitingNCT06002789Phase 2
• ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal CancerRecruitingNCT05815082Phase 3
• Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer PatientsRecruitingNCT05797467Phase 3
• Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNARecruitingNCT05797077Phase 3
• ctDNA as a Assisted Diagnosis, Early Intervention and Prognostic Marker for Peritoneal Metastases From Colorectal CancerRecruitingNCT04752930Not applicable
• The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal CancerNot yet recruitingNCT03923335
• Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 DiagnosisRecruitingNCT03748485Not applicable
• Estimating Lymphocyte Counts from DNA MethylationCompletedNCT06586307
• Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous ThrombembolismCompletedNCT06440044
• Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal CancerActive, not recruitingNCT05953662Not applicable
• mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal CancerStatus unknownNCT05480280Phase 2
• mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRCCompletedNCT04895137Phase 2
• Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerStatus unknownNCT04221854Not applicable
• Prognostic Biomarker for CRCStatus unknownNCT03928652
• The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal CancerStatus unknownNCT03416478
• Multiple Screening Methods for the Detection of Chinese Colorectal Advanced Adenomatous Polyps and CancerStatus unknownNCT03411707
• Clinical Analysis of HIPEC for T4 Colorectal Cancer After SurgeryStatus unknownNCT03221608Phase 3
• Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical SurgeryStatus unknownNCT02796820Phase 3
• Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal CancerStatus unknownNCT02785146Phase 3
• DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal CancerStatus unknownNCT02415699Phase 2/3
• Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic TreatmentStatus unknownNCT02226289Phase 2
• Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to OxaliplatinStatus unknownNCT02087475Phase 3